Company: REVB
Filing Date: 2025-01-30
Form Type: 8-K
Source: 0000950170-25-011197
Chunk: 2

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-01-30
Form: 8-K
Item: Item 5.03
Chunk 2
---
 of the Class G Common Stock Warrants, to the number of shares for which they are exercisable) based upon the VWAP of the Company’s common stock in the days following the effected ate of the Reverse Stock Split. Furthermore, the number of shares of common stock available for issuance under the Company’s equity incentive plans were proportionately adjusted for the Reverse Stock Split ratio, such that fewer shares are subject to such plans.

The new CUSIP number for common stock following the Reverse Stock Split is 76135L606. For more information about the Reverse Stock Split, see the Company’s definitive proxy statement filed with the Securities and Exchange Commission on December 16, 2024.

The text of the Certificate of Amendment is filed as Exhibit 3.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.